EHC News & Analysis
3 articles
Market Mood
Encompass Health (EHC) Insider Sells 8,906 Shares Amid Revenue Growth
John Patrick Darby, EVP and general counsel of Encompass Health Corporation (NYSE:EHC), sold 8,906 shares of stock on August 10, valuing the transaction at an average price of $125.95. This sale represents 11% of his direct common stock holdings, leaving him with 75,041 shares. Encompass Health reported $6.2 billion in revenue and $621 million in net income, leading to a market capitalization of $12.5 billion as of the same date. This insider transaction occurs within a context of stable revenue and a significant market presence, highlighting potential developments in investor confidence and company performance.
Read More: Encompass Health (EHC) Insider Sells 8,906 Shares Amid Revenue Growth
Encompass Health's (EHC) CFO Sold 18,869 Shares for $2.4 Million
Douglas E. Coltharp, CFO of Encompass Health Corporation (NYSE:EHC), sold 18,869 shares on August 10 for approximately $2.4 million, at a weighted average sale price of $125.38. The market close on the same day valued shares at $125.81. Following this transaction, Coltharp maintains an equity interest of 241,000 shares, valued around $30.4 million. Encompass Health's market capitalization is reported at $12.5 billion, with trailing twelve-month revenue of $6.2 billion and net income of $621.0 million, reflecting its operational scale in healthcare services, which is important for investor considerations.
Read More: Encompass Health's (EHC) CFO Sold 18,869 Shares for $2.4 Million
Encompass Health (EHC) CEO Sells 173,000 Shares for $125.47 Each
On August 10, Encompass Health Corporation (NYSE:EHC) CEO Mark J. Tarr sold approximately 173,000 shares at a weighted average price of $125.47. The shares had a post-transaction market value of $125.81, with sale prices ranging from $124.93 to $126.22. This sale reduced Tarr's direct holdings by 39%, though he retains 268,000 shares valued over $33 million. Encompass Health operates with a market capitalization of $12.5 billion and generated TTM revenues of $6.2 billion, making it a key player in post-acute healthcare.
Read More: Encompass Health (EHC) CEO Sells 173,000 Shares for $125.47 Each